UCB Launched Wear It Out Patient Program

The initiative offers custom-designed t-shirts to individuals managing specific inflammatory conditions.

Updated on Oct. 13, 2026 in Fashion

Gouache-painted illustration of a neatly folded cotton t-shirt, rendered in a warm, muted palette to signify comfort and patient support.
Biopharmaceutical firm UCB has introduced a new initiative providing custom apparel designed for patients living with inflammatory skin and joint conditions. AI Illustration. Upload story photo >

Live Poll

Do you trust pharmaceutical community programs to prioritize patient support over drug marketing?

Biopharmaceutical company UCB has launched the Wear It Out program, providing custom t-shirts to patients living with hidradenitis suppurativa, plaque psoriasis, and psoriatic arthritis. Participants receive the apparel after sharing their personal health stories through the campaign website.

Why it matters

The program addresses physical discomforts patients face, such as skin flaking or joint pain, when selecting clothing. By encouraging story-sharing, it seeks to foster community support among those managing chronic inflammatory diseases.

The shirts are crafted from a bamboo and organic cotton blend and feature designs by artist Sophia Yeshi. In September 2026, UCB reported $56.9 million in advertising expenditures for Bimzelx, an FDA-approved biologic for these conditions.

The players

UCB

This global biopharmaceutical company focuses on developing treatments for neurology and immunology conditions.

Sophia Yeshi

She is a visual artist who collaborated with disease advocates to design the collection of t-shirts for this program.

Bimzelx

This is an FDA-approved biologic medication used for the treatment of inflammatory conditions like plaque psoriasis.

The details

Patients gain access to the clothing line by submitting audio or video accounts of their diagnosis via the campaign portal. The initiative also connects participants to educational resources regarding their health and information on the drug Bimzelx.

Timeline

  1. UCB spent $56.9 million on Bimzelx advertising in September 2026.

  2. The Wear It Out program was launched in October 2026.

Culture Shift

This program reflects the growing integration of patient advocacy with digital marketing strategies in the pharmaceutical sector. It marks a departure from traditional advertising by incentivizing brand engagement through personalized support networks.

Patients living with these conditions can now access apparel designed specifically for their physical needs, such as managing sensitivities related to skin flaking. Participants should visit the official portal to review educational resources and eligibility requirements for the program.

The takeaway

Patients managing chronic inflammatory conditions should evaluate how lifestyle initiatives integrate with their existing medical treatment plans. Always consult with a healthcare professional before making decisions based on promotional health materials.

Further reading

Learn more about the latest developments in Fashion and health-integrated apparel.

Live Poll

Do you trust pharmaceutical community programs to prioritize patient support over drug marketing?